Abstract
Three episodes of bacteremia occurred in the course of prosthetic valve endocarditis caused by an extended-spectrum-β-lactamase (ESRL)-producing Klebsiella pneumoniae strain. The second isolate developed resistance to ciprofloxacin and the third isolate to piperacillin-tazobactam (PIP-TZ) following sequential therapy with each agent. The first isolate was resistant to PIP-TZ only at high inocula, the second isolate acquired increased transcription of the acrA gene, and the third isolate became resistant to PIP-TZ due to loss of β-lactamase inhibition by TZ. We question if and how PIP-TZ susceptibility should be reported for ESBL-producing Enterobacteriaceae.
| Original language | English |
|---|---|
| Pages (from-to) | 3179-3182 |
| Number of pages | 4 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 50 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2006 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Endocarditis caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: Emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver